Delivery Order 75F40122D00006-75F40122F19001
Award Date 4/20/22
Potential Completion Date 2/15/24
Potential Value $619K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,215,324.40 Firm Fixed Price Delivery Order issued by the Food and Drug Administration (FDA) to Labstat International Inc., a leading analytical testing laboratory in Kitchener, Ontario. The contract is for Tobacco Lab Analysis Services and is part of a larger $45 million Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Labstat to provide laboratory services in support of the FDA's regulatory oversight of tobacco products. The contract covers a range of technical...
- This is a federal contract award from the Food and Drug Administration (FDA) to Labstat International Inc., a Canadian-based for-profit limited liability company that specializes in analytical testing services for tobacco, e-cigarette, cannabis, and CBD products. The contract is for $355,400.98 and is for "Tobacco Lab Analysis Services - Novel Oral Nicotine Products." It is a firm fixed-price delivery order contract with an ultimate completion date of September 29, 2026. Labstat...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
- This federal contract award to Labstat International Inc., a leading analytical testing laboratory, is for a stability study of cigarette tobacco filler on behalf of the Food and Drug Administration (FDA). The firm fixed price delivery order is valued at $112,994.60 and has a completion date of June 13, 2016. Labstat has been awarded multiple prior contracts from the FDA to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products in support...
- This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by the...
- The U.S. Food and Drug Administration (FDA) awarded a $437,684.94 firm fixed price delivery order to Labstat International Inc., a leading analytical testing laboratory, to provide tobacco lab analysis services. The scope includes generating and quantitating benzo[a]pyrene, tar, nicotine, and carbon monoxide from pipe tobacco mainstream smoke under a new smoking regimen. This delivery order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract...
- The Food and Drug Administration awarded a definitive contract valued at $1,010,475.20 to Labstat International Inc., a foreign-owned for-profit organization, to evaluate the microbial parameters of electronic nicotine delivery system e-liquids. The contract calls for the contractor to validate test methods, conduct antimicrobial effectiveness testing, and measure water activity, total aerobic counts, endotoxins, glucans, and nitrosamines in laboratory-prepared and commercial e-liquid samples...
- This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for $679,680.00. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Under this task order, LBERI will conduct an assessment of tobacco products and tobacco product constituents' genetic toxicology using in vitro assays to compare the...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $86,713.56 firm-fixed price purchase order to GD USA Inc. (doing business as Acma), a foreign-owned, for-profit, and woman-owned manufacturer of goods. The contract is for an e-cigarette smoking machine with accessories to support the FDA's Center for Tobacco Products' regulatory responsibilities under the Tobacco Control Act. The FDA's Southeast Tobacco Laboratory requires this specialized equipment...
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to GD USA Inc., a foreign-owned, for-profit, woman-owned manufacturer of specialized laboratory equipment. The $99,672.00 contract is for the provision of electronic cigarette (e-cigarette) smoking machine services and qualification. The contract has no set-aside designation and a performance period that extends to August 4, 2030. GD USA Inc. primarily supports the FDA's Center for Tobacco...